| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |